throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`MYLAN PHARMACEUTICALS INC.
`Petitioner
`
`v.
`
`QUALICAPS CO. LTD.
`Patent Owner
`
`U.S. Patent No. 6,649,180
`Filing Date: April 13, 2000
`Issue Date: November 18, 2003
`Title: HARD CAPSULE FORMED OF CELLULOSE ETHER FILM WITH A
`SPECIFIC CONTENT OF METHOXYL AND HYDROXYPROPOXYL
`GROUPS
`________________
`
`Inter Partes Review No. 2017-00203
`
`
`
`DECLARATION OF MR. JONATHAN D. OLINGER IN SUPPORT OF
`PETITIONER’S UNOPPOSED MOTION FOR PRO HAC VICE
`ADMISSION UNDER 37 C.F.R. § 42.10(c)
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1015 - Page 1
`
`

`

`
`
`
`
`I, Jonathan D. Olinger, am over eighteen years of age and would be
`
`competent to testify as to the matters set forth herein if called upon to do so.
`
`1. I am a member in good standing of the state bar of Georgia, as well
`
`as the following Federal Courts:
`
`a. U.S. District Court for the Northern District of Georgia;
`
`b. U.S. District Court for the Eastern District of Texas; and
`
`c. U.S. District Court for the District of Colorado.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`No sanction or contempt citation has been imposed against me by any
`
`court or administrative body.
`
`During the past 3 years, I have applied to appear pro hac vice before
`
`the United States Patent and Trademark Office in the following
`
`proceedings:
`
`a. Under Armour, Inc. v. Adidas AG, Case IPR2015-00697;
`
`b. Under Armour, Inc. v. Adidas AG, Case IPR2015-00698;
`
`c. Under Armour, Inc. v. Adidas AG, Case IPR2015-00700;
`
`d. Under Armour, Inc. v. Adidas AG, Case IPR2015-01528; and
`
`- 1 -
`
`2.
`
`3.
`
`4.
`
`5.
`
`
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1015 - Page 2
`
`

`

`
`
`6.
`
`
`
`e. Under Armour, Inc. v. Adidas AG, Case IPR2015-01532.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42
`
`of 37 C.F.R.
`
`7.
`
`I will be subjected to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary jurisdiction under
`
`37 C.F.R. § 11.19(a).
`
`8. I am familiar with the subject matter at issue in the proceeding. I am
`
`counsel for Mylan Pharmaceuticals, Inc. in a co-pending litigation,
`
`Warner Chilcott (US), LLC et al. v. Mylan Pharmaceuticals, Inc., et
`
`al., Case No. 2:15-cv-01740-JRG-RSP (E.D. Texas) in which U.S.
`
`Patent No. 6,649,180 is asserted against Petitioner. In the co-pending
`
`litigation, I have reviewed prior art, developed validity arguments,
`
`developed claim construction arguments, managed fact and expert
`
`discovery, and drafted motion papers. I therefore have an established
`
`familiarity with the subject matter at issue in the proceeding,
`
`including the prior art relied upon in the Petition.
`
`9.
`
`I have been a litigating attorney in private practice since 2010, with
`
`trial experience in numerous litigations involving patent infringement
`
`
`
`- 2 -
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1015 - Page 3
`
`

`

`and validity in federal eourts across the country, including experience
`
`injury and bench trials and appeals in the Federal Circuit.
`
`10.
`
`An abbreviated summary of my professional biography is Attachment
`
`A to this Declaration.
`
`Date: December 21,2016
`
`Jonathan D. Olinger
`Kjjf^trick, Townsend & Stockton LLP
`1100 Peachtree Street NE, Suite 2800
`Atlanta, GA 30309-4528
`
`12172643V. 1
`
`-3 -
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1015 - Page 4
`
`

`

`
`
`EXHIBIT A
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1015 - Page 5
`
`

`

`11/29/2016
`
`{1
`
`KILPATRICK
`
`TOWNSEND
`
`Kilpatrick Townsend & Stockton LLP - Olinger, Jonathan D.
`
`
`
`Jonathan D. Olinger
`ASSOCIATE
`
`Services
`
`Intellectual Property; Patent Litigation; Intellectual Property Litigation
`
`Industries
`
`Aerospace & Defense; Pharmaceuticals; Technology & Software; Telecommunications
`
`Jonathan Olinger focuses his practice on patent litigation matters. His practice covers a range of technologies, including
`
`pharmaceuticals, software-related systems, and telecommunications. Mr. Olinger has experience in all phases of patent
`
`litigation, including fact and expert discovery, depositions, claim construction, motion practice and trial.
`
`Prior to joining the firm, Mr. Olinger worked as an associate in the Atlanta office of a national law firm. Before entering private
`
`practice, Mr. Olinger was a law clerk for the Honorable Timothy C. Batten, Sr., United States District Judge for the Northern
`District of Georgia.
`
`Professional & Community Activities
`Georgia Bar Association, Intellectual Property Section, Committee Chair (2012-Present)
`
`Atlanta Intellectual Property Inn of Court, Member
`
`Institute for Responsible Citizenship, Board of Trustees, Member (2008-Present)
`
`Education
`
`- Stanford Law School, J.D. (2008)
`
`- Georgia Institute of Technology, B.S., Aerospace Engineering, Minors in Law, Science and Technology (2005)
`with highest honors
`
`Bar Admissions
`
`- Georgia (2009)
`
`Admissions
`
`- U.S. District Court for the Northern District of Georgia (2010)
`
`- Georgia Superior Court (2009)
`
`Clerkships
`
`- U.S. District Court for the Northern District of Georgia — Honorable Timothy C. Batten, Sr. (Aug 2008-Aug 2010)
`
`Suite 2800, 1100 Peachtree Street NE
`
`_
`_
`_
`_
`_
`Atlanta, GA, 30309-4528
`, Petitioner M Ian Pharmaceuticals Inc. - Exhibit 1015 - Page 6
`.
`,
`http://www.kiIpatricktownsend.com/en/Who_We_Are/Professionals/O/OIingerJon hanD16245.aspx
`
`1/2
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1015 - Page 6
`
`

`

`11/29/2016
`
`USA
`
`t +1 404.745.2426.
`
`f+1 404.541.3326
`
`e-mailvcardprint full bio
`
`Kilpatrick Townsend & Stockton LLP - Olinger, Jonathan D.
`
`Jonathan D. Olinger
`
`Experience Highlights
`
`Shire LLC v. Watson Pharmaceuticals, Inc.
`
`Represented Watson Pharmaceuticals, Inc.
`treat ADHD. more
`
`in patent litigation relating to generic forms of guanfacine hydrochloride used to
`
`Intellectual Ventures v. Motorola Mobility LLC
`
`The firm served as lead counsel on behalf of Motorola Mobility, in a lawsuit involving allegations of patent infringement related
`to mobile phone more
`
`Monec Holding AG v. Motorola Mobility, Inc.
`
`The firm served as lead counsel for Motorola Mobility in a patent infringement suit filed by Monec in the District of Delaware.
`The parties more
`
`Inter partes review challenge for C&D Zodiac
`
`Kilpatrick Townsend successfully instituted an inter partes review of U.S. Patent No. 8,590,838, titled “Aircraft Interior more
`
`, Petitioner M Ian Pharmaceuticals Inc. - Exhibit 1015 - Page 7
`.
`.
`http://www.kiIpatncktownsend.com/en/Who_We_Are/ProfessIonals/O/OIIngerJon hanD16245.aspx
`
`2/2
`
`Petitioner Mylan Pharmaceuticals Inc. - Exhibit 1015 - Page 7
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket